<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36971206</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1755-5949</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>CNS neuroscience &amp; therapeutics</Title><ISOAbbreviation>CNS Neurosci Ther</ISOAbbreviation></Journal><ArticleTitle>Brain metabolic signatures in patients with genetic and nongenetic amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>2530</StartPage><EndPage>2539</EndPage><MedlinePgn>2530-2539</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cns.14193</ELocationID><Abstract><AbstractText Label="AIMS">To study the brain metabolic signature in Chinese amyotrophic lateral sclerosis (ALS) patients and compare the difference in brain metabolic patterns between ALS with and without genetic variants.</AbstractText><AbstractText Label="METHODS">We included 146 patients with ALS and 128 healthy controls (HCs). All patients with ALS underwent genetic testing to screen for ALS related genetic variants and were then divided into genetic (n&#x2009;=&#x2009;22) and nongenetic ALS (n&#x2009;=&#x2009;93) subgroups. All participants underwent brain <sup>18</sup> F-FDG-PET scans. Group comparisons were performed using the two-sample t-test model of SPM12.</AbstractText><AbstractText Label="RESULTS">We identified a large of hypometabolic clusters in ALS patients as compared with HCs, especially in the bilateral basal ganglia, midbrain, and cerebellum. Moreover, hypometabolism in the bilateral temporal lobe, precentral gyrus and hypermetabolism in the left anterior cingulate, occipital lobe, and bilateral frontal lobe were also found in ALS patients as compared with HCs. Compared with nongenetic ALS patients, genetic ALS patients showed hypometabolism in the right postcentral gyrus, precuneus, and middle occipital gyrus. The incidence of sensory disturbance in patients with genetic ALS was higher than that in patients with nongenetic ALS (5 of 22 [22.72%] vs. 7 of 93 [7.52%], p&#x2009;=&#x2009;0.036).</AbstractText><AbstractText Label="CONCLUSIONS">Our investigation provided unprecedented evidence of relative hypometabolism in the midbrain and cerebellum in ALS patients. Genetic ALS patients showed a specific signature of brain metabolism and a higher incidence of sensory disturbance, indicating that genetic factors may be an underlying cause affecting the brain metabolism and increasing the risk of sensory disturbance in ALS.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. CNS Neuroscience &amp; Therapeutics published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Pan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, The Central Hospital of Shaoyang, Shaoyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Yongxiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Central Hospital of Shaoyang, Shaoyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wanzhen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yanchun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Liangjuan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jifeng</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3658-3928</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Lu</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3393-8578</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7646-5950</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Beisha</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Biological Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Junling</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5117-5204</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>CNS Neurosci Ther</MedlineTA><NlmUniqueID>101473265</NlmUniqueID><ISSNLinking>1755-5930</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0Z5B2CJX4D</RegistryNumber><NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019788" MajorTopicYN="N">Fluorodeoxyglucose F18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008636" MajorTopicYN="N">Mesencephalon</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">18F-FDG-PET</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">brain metabolism</Keyword><Keyword MajorTopicYN="N">genetic</Keyword><Keyword MajorTopicYN="N">whole exome sequencing</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest associated with the contents of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36971206</ArticleId><ArticleId IdType="pmc">PMC10401109</ArticleId><ArticleId IdType="doi">10.1111/cns.14193</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al&#x2010;Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162&#x2010;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chio A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17(1):94&#x2010;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al&#x2010;Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S, Goizet C, Soulages A, Vallat JM, Masson GL. Genetics of amyotrophic lateral sclerosis: a review. J Neurol Sci. 2019;399:217&#x2010;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Li HF, Wu ZY. Genotype&#x2010;phenotype correlations of amyotrophic lateral sclerosis. Transl Neurodegener. 2016;5:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4738789</ArticleId><ArticleId IdType="pubmed">26843957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Langen KJ, Regard M, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand. 1992;85(2):81&#x2010;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">1574993</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman JM, Mazziotta JC, Hawk TC, Sumida R. Cerebral glucose utilization in motor neuron disease. Arch Neurol. 1992;49(8):849&#x2010;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">1524517</ArticleId></ArticleIdList></Reference><Reference><Citation>Cistaro A, Valentini MC, Chio A, et al. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging. 2012;39(2):251&#x2010;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">22089661</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagani M, Chio A, Valentini MC, et al. Functional pattern of brain FDG&#x2010;PET in amyotrophic lateral sclerosis. Neurology. 2014;83(12):1067&#x2010;1074.</Citation><ArticleIdList><ArticleId IdType="pubmed">25122207</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A, Pagani M, Cistaro A, et al. 18F&#x2010;FDG&#x2010;PET correlates of cognitive impairment in ALS. Neurology. 2016;86(1):44&#x2010;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">26590270</ArticleId></ArticleIdList></Reference><Reference><Citation>Renard D, Collombier L, Castelnovo G, Fourcade G, Kotzki PO, LaBauge P. Brain FDG&#x2010;PET changes in ALS and ALS&#x2010;FTD. Acta Neurol Belg. 2011;111(4):306&#x2010;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">22368970</ArticleId></ArticleIdList></Reference><Reference><Citation>Cistaro A, Pagani M, Montuschi A, et al. The metabolic signature of C9ORF72&#x2010;related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging. 2014;41(5):844&#x2010;852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957062</ArticleId><ArticleId IdType="pubmed">24445987</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vocht J, Blommaert J, Devrome M, et al. Use of multimodal imaging and clinical biomarkers in Presymptomatic carriers of C9orf72 repeat expansion. JAMA Neurol. 2020;77(8):1008&#x2010;1017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417970</ArticleId><ArticleId IdType="pubmed">32421156</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Laere K, Vanhee A, Verschueren J, et al. Value of 18fluorodeoxyglucose&#x2010;positron&#x2010;emission tomography in amyotrophic lateral sclerosis: a prospective study. JAMA Neurol. 2014;71(5):553&#x2010;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">24615479</ArticleId></ArticleIdList></Reference><Reference><Citation>Diehl&#x2010;Schmid J, Licata A, Goldhardt O, et al. FDG&#x2010;PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations. Transl Psychiatry. 2019;9(1):54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6355852</ArticleId><ArticleId IdType="pubmed">30705258</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta&#x2010;analysis. J Neurol Neurosurg Psychiatry. 2017;88(7):540&#x2010;549.</Citation><ArticleIdList><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, et al. A revision of the El Escorial criteria&#x2014;2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5&#x2013;6):291&#x2010;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Yuan Y, Wang M, et al. Mutation spectrum of amyotrophic lateral sclerosis in central South China. Neurobiol Aging. 2021;107:181&#x2010;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">34275688</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high&#x2010;throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2938201</ArticleId><ArticleId IdType="pubmed">20601685</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhao T, Zhang Y, et al. Performance evaluation of pathogenicity&#x2010;computation methods for missense variants. Nucleic Acids Res. 2018;46(15):7793&#x2010;7804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6125674</ArticleId><ArticleId IdType="pubmed">30060008</ArticleId></ArticleIdList></Reference><Reference><Citation>Varrone A, Asenbaum S, Vander Borght T, et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36(12):2103&#x2010;2110.</Citation><ArticleIdList><ArticleId IdType="pubmed">19838705</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A, Moglia C, Manera U, et al. Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F&#x2010;FDG&#x2010;PET study. J Neurol Neurosurg Psychiatry. 2020;92:357&#x2010;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">33229451</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia M, Wang J, He Y. BrainNet viewer: a network visualization tool for human brain connectomics. PLoS One. 2013;8(7):e68910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3701683</ArticleId><ArticleId IdType="pubmed">23861951</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong Y, Park KC, Cho SS, et al. Pattern of glucose hypometabolism in frontotemporal dementia with motor neuron disease. Neurology. 2005;64(4):734&#x2010;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">15728305</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias&#x2010;Guiu JA, Pytel V, Cabrera&#x2010;Martin MN, et al. Amyloid&#x2010; and FDG&#x2010;PET imaging in amyotrophic lateral sclerosis. Eur J Nucl Med Mol Imaging. 2016;43(11):2050&#x2010;2060.</Citation><ArticleIdList><ArticleId IdType="pubmed">27262702</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanovello M, Soraru G, Campi C, et al. Brain stem glucose hypermetabolism in amyotrophic lateral sclerosis/frontotemporal dementia and shortened survival: an 18F&#x2010;FDG PET/MRI study. J Nucl Med. 2022;63(5):777&#x2010;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">34503963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Pagani M, Agosta F, Calvo A, Cistaro A, Filippi M. Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes. Lancet Neurol. 2014;13(12):1228&#x2010;1240.</Citation><ArticleIdList><ArticleId IdType="pubmed">25453462</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Chipika RH, Christidi F, et al. Genotype&#x2010;associated cerebellar profiles in ALS: focal cerebellar pathology and cerebro&#x2010;cerebellar connectivity alterations. J Neurol Neurosurg Psychiatry. 2021;92(11):1197&#x2010;1205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522463</ArticleId><ArticleId IdType="pubmed">34168085</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlacchio A, Babalini C, Borreca A, et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133(Pt 2):591&#x2010;598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2822627</ArticleId><ArticleId IdType="pubmed">20110243</ArticleId></ArticleIdList></Reference><Reference><Citation>Mochizuki Y, Mizutani T, Shimizu T, Kawata A. Proportional neuronal loss between the primary motor and sensory cortex in amyotrophic lateral sclerosis. Neurosci Lett. 2011;503(1):73&#x2010;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">21871950</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T, Nakayama Y, Funai A, et al. Progressive deterioration of sensory cortex excitability in advanced amyotrophic lateral sclerosis with invasive ventilation. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(1&#x2013;2):147&#x2010;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">31852262</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardone R, Golaszewski S, Thomschewski A, et al. Disinhibition of sensory cortex in patients with amyotrophic lateral sclerosis. Neurosci Lett. 2020;722:134860.</Citation><ArticleIdList><ArticleId IdType="pubmed">32097703</ArticleId></ArticleIdList></Reference><Reference><Citation>Li TM, Alberman E, Swash M. Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. J Neurol Neurosurg Psychiatry. 1988;51(6):778&#x2010;784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1033147</ArticleId><ArticleId IdType="pubmed">3404186</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegat A, Bouhour F, Mouzat K, et al. Electrophysiological characterization of C9ORF72&#x2010;associated amyotrophic lateral sclerosis: a retrospective study. Eur Neurol. 2019;82(4&#x2013;6):106&#x2010;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">32018264</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto H, Akamatsu M, Hirano M, et al. Multiple system involvement in a Japanese patient with a V31A mutation in the SOD1 gene. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(3&#x2013;4):312&#x2010;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">24611504</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A, Warita H, Takahashi T, et al. Prominent sensory involvement in a case of familial amyotrophic lateral sclerosis carrying the L8V SOD1 mutation. Clin Neurol Neurosurg. 2016;150:194&#x2010;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">27543311</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla Bella E, Rigamonti A, Mantero V, et al. Heterozygous D90A&#x2010;SOD1 mutation in a patient with facial onset sensory motor neuronopathy (FOSMN) syndrome: a bridge to amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2014;85(9):1009&#x2010;1011.</Citation><ArticleIdList><ArticleId IdType="pubmed">24591457</ArticleId></ArticleIdList></Reference><Reference><Citation>Chipika RH, Mulkerrin G, Murad A, Lope J, Hardiman O, Bede P. Alterations in somatosensory, visual and auditory pathways in amyotrophic lateral sclerosis: an under&#x2010;recognised facet of ALS. J Integr Neurosci. 2022;21(3):88.</Citation><ArticleIdList><ArticleId IdType="pubmed">35633169</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Murad A, Lope J, Hardiman O, Chang KM. Clusters of anatomical disease&#x2010;burden patterns in ALS: a data&#x2010;driven approach confirms radiological subtypes. J Neurol. 2022;269(8):4404&#x2010;4413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9294023</ArticleId><ArticleId IdType="pubmed">35333981</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalakas MC, Hatazawa J, Brooks RA, Di Chiro G. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis. Ann Neurol. 1987;22(5):580&#x2010;586.</Citation><ArticleIdList><ArticleId IdType="pubmed">3501273</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Valsasina P, Riva N, et al. The cortical signature of amyotrophic lateral sclerosis. PLoS One. 2012;7(8):e42816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3412820</ArticleId><ArticleId IdType="pubmed">22880116</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Fang T, Wang Y, et al. Occipital cortical gyrification reductions associate with decreased functional connectivity in amyotrophic lateral sclerosis. Brain Imaging Behav. 2017;11(1):1&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26780240</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Bokde A, Elamin M, et al. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry. 2013;84(7):766&#x2010;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">23085933</ArticleId></ArticleIdList></Reference><Reference><Citation>Boxer AL, Mackenzie IR, Boeve BF, et al. Clinical, neuroimaging and neuropathological features of a new chromosome 9p&#x2010;linked FTD&#x2010;ALS family. J Neurol Neurosurg Psychiatry. 2011;82(2):196&#x2010;203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3017222</ArticleId><ArticleId IdType="pubmed">20562461</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawata A, Kato S, Shimizu T, et al. Aberrant splicing of human Cu/Zn superoxide dismutase (SOD1) RNA transcripts. Neuroreport. 2000;11(12):2649&#x2010;2653.</Citation><ArticleIdList><ArticleId IdType="pubmed">10976937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Zhang D, Ji J, Wang Y, Zhang R. Central retina changes in Parkinson's disease: a systematic review and meta&#x2010;analysis. J Neurol. 2021;268(12):4646&#x2010;4654.</Citation><ArticleIdList><ArticleId IdType="pubmed">33174132</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider M, M&#xfc;ller HP, Lauda F, et al. Retinal single&#x2010;layer analysis in parkinsonian syndromes: an optical coherence tomography study. J Neural Transm (Vienna). 2014;121(1):41&#x2010;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">23907408</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong YT, Hilal S, Cheung CY, et al. Retinal neurodegeneration on optical coherence tomography and cerebral atrophy. Neurosci Lett. 2015;584:12&#x2010;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">25451722</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Liu X, Fu J, et al. Selective and inverse U&#x2010;shaped curve alteration of the retinal nerve in amyotrophic lateral sclerosis: a potential Mirror of the disease. Front Aging Neurosci. 2021;13:783431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8770270</ArticleId><ArticleId IdType="pubmed">35069179</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez L, Dube U, Davis AA, et al. Pleiotropic effects of variants in dementia genes in Parkinson disease. Front Neurosci. 2018;12:230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5902712</ArticleId><ArticleId IdType="pubmed">29692703</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>